Literature DB >> 26269592

Signal Transduction and Intracellular Trafficking by the Interleukin 36 Receptor.

Siddhartha S Saha1, Divyendu Singh1, Ernest L Raymond2, Rajkumar Ganesan2, Gary Caviness2, Christine Grimaldi2, Joseph R Woska2, Detlev Mennerich2, Su-Ellen Brown2, M Lamine Mbow3, C Cheng Kao4.   

Abstract

Improper signaling of the IL-36 receptor (IL-36R), a member of the IL-1 receptor family, has been associated with various inflammation-associated diseases. However, the requirements for IL-36R signal transduction remain poorly characterized. This work seeks to define the requirements for IL-36R signaling and intracellular trafficking. In the absence of cognate agonists, IL-36R was endocytosed and recycled to the plasma membrane. In the presence of IL-36, IL-36R increased accumulation in LAMP1+ lysosomes. Endocytosis predominantly used a clathrin-mediated pathway, and the accumulation of the IL-36R in lysosomes did not result in increased receptor turnover. The ubiquitin-binding Tollip protein contributed to IL-36R signaling and increased the accumulation of both subunits of the IL-36R.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  IL-1; Tollip; endocytosis; immunology; interleukin 36 receptor; signal transduction; trafficking

Mesh:

Substances:

Year:  2015        PMID: 26269592      PMCID: PMC4583048          DOI: 10.1074/jbc.M115.653378

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

1.  Heat shock protein 70 is secreted from tumor cells by a nonclassical pathway involving lysosomal endosomes.

Authors:  Salamatu S Mambula; Stuart K Calderwood
Journal:  J Immunol       Date:  2006-12-01       Impact factor: 5.422

2.  A guided tour into subcellular colocalization analysis in light microscopy.

Authors:  S Bolte; F P Cordelières
Journal:  J Microsc       Date:  2006-12       Impact factor: 1.758

Review 3.  The interleukin-1 family: back to the future.

Authors:  Cecilia Garlanda; Charles A Dinarello; Alberto Mantovani
Journal:  Immunity       Date:  2013-12-12       Impact factor: 31.745

4.  Negative regulation of toll-like receptor-mediated signaling by Tollip.

Authors:  Guolong Zhang; Sankar Ghosh
Journal:  J Biol Chem       Date:  2001-12-18       Impact factor: 5.157

5.  MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways.

Authors:  R Medzhitov; P Preston-Hurlburt; E Kopp; A Stadlen; C Chen; S Ghosh; C A Janeway
Journal:  Mol Cell       Date:  1998-08       Impact factor: 17.970

Review 6.  Biology of IL-36 cytokines and their role in disease.

Authors:  Mark S Gresnigt; Frank L van de Veerdonk
Journal:  Semin Immunol       Date:  2013-12-17       Impact factor: 11.130

7.  The human antimicrobial peptide LL-37, but not the mouse ortholog, mCRAMP, can stimulate signaling by poly(I:C) through a FPRL1-dependent pathway.

Authors:  Divyendu Singh; Rongsu Qi; Jarrat L Jordan; Lani San Mateo; C Cheng Kao
Journal:  J Biol Chem       Date:  2013-02-05       Impact factor: 5.157

Review 8.  The interleukin-1 receptor family.

Authors:  Diana Boraschi; Aldo Tagliabue
Journal:  Semin Immunol       Date:  2013-11-15       Impact factor: 11.130

9.  Aggregation of lipid rafts accompanies signaling via the T cell antigen receptor.

Authors:  P W Janes; S C Ley; A I Magee
Journal:  J Cell Biol       Date:  1999-10-18       Impact factor: 10.539

10.  A novel class of clathrin-coated vesicles budding from endosomes.

Authors:  W Stoorvogel; V Oorschot; H J Geuze
Journal:  J Cell Biol       Date:  1996-01       Impact factor: 10.539

View more
  9 in total

1.  E3 Ubiquitin Ligase RNF125 Activates Interleukin-36 Receptor Signaling and Contributes to Its Turnover.

Authors:  Siddhartha S Saha; Gary Caviness; Guanghui Yi; Ernest L Raymond; M Lamine Mbow; C Cheng Kao
Journal:  J Innate Immun       Date:  2017-11-25       Impact factor: 7.349

2.  Structural and Functional Attributes of the Interleukin-36 Receptor.

Authors:  Guanghui Yi; Joel A Ybe; Siddhartha S Saha; Gary Caviness; Ernest Raymond; Rajkumar Ganesan; M Lamine Mbow; C Cheng Kao
Journal:  J Biol Chem       Date:  2016-06-15       Impact factor: 5.157

3.  Toll-Interacting Protein, Tollip, Inhibits IL-13-Mediated Pulmonary Eosinophilic Inflammation in Mice.

Authors:  Yoko Ito; Niccolette Schaefer; Amelia Sanchez; David Francisco; Rafeul Alam; Richard J Martin; Julie G Ledford; Connor Stevenson; Di Jiang; Liwu Li; Monica Kraft; Hong Wei Chu
Journal:  J Innate Immun       Date:  2018-01-27       Impact factor: 7.349

Review 4.  Interleukin-36: Structure, Signaling and Function.

Authors:  Li Zhou; Viktor Todorovic
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 5.  Cytokine Receptor Endocytosis: New Kinase Activity-Dependent and -Independent Roles of PI3K.

Authors:  Ping-Hung Chen; Huiyu Yao; Lily Jun-Shen Huang
Journal:  Front Endocrinol (Lausanne)       Date:  2017-05-01       Impact factor: 5.555

Review 6.  Interleukin-36 in Infectious and Inflammatory Skin Diseases.

Authors:  Anna-Lena Buhl; Joerg Wenzel
Journal:  Front Immunol       Date:  2019-05-24       Impact factor: 7.561

7.  Retrospective analysis of model-based predictivity of human pharmacokinetics for anti-IL-36R monoclonal antibody MAB92 using a rat anti-mouse IL-36R monoclonal antibody and RNA expression data (FANTOM5).

Authors:  Jennifer Ahlberg; Craig Giragossian; Hua Li; Maria Myzithras; Ernie Raymond; Gary Caviness; Christine Grimaldi; Su-Ellen Brown; Rocio Perez; Danlin Yang; Rachel Kroe-Barrett; David Joseph; Chandrasena Pamulapati; Kelly Coble; Peter Ruus; Joseph R Woska; Rajkumar Ganesan; Steven Hansel; M Lamine Mbow
Journal:  MAbs       Date:  2019-06-04       Impact factor: 5.857

Review 8.  Toll-interacting protein impacts on inflammation, autophagy, and vacuole trafficking in human disease.

Authors:  Xiaoyun Li; Gillian C Goobie; Yingze Zhang
Journal:  J Mol Med (Berl)       Date:  2020-10-31       Impact factor: 4.599

9.  Generation and functional characterization of anti-human and anti-mouse IL-36R antagonist monoclonal antibodies.

Authors:  Rajkumar Ganesan; Ernest L Raymond; Detlev Mennerich; Joseph R Woska; Gary Caviness; Christine Grimaldi; Jennifer Ahlberg; Rocio Perez; Simon Roberts; Danlin Yang; Kavita Jerath; Kristopher Truncali; Lee Frego; Eliud Sepulveda; Priyanka Gupta; Su-Ellen Brown; Michael D Howell; Keith A Canada; Rachel Kroe-Barrett; Jay S Fine; Sanjaya Singh; M Lamine Mbow
Journal:  MAbs       Date:  2017-07-20       Impact factor: 5.857

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.